NIH Launches $50 Million Autism Data Science Initiative
The National Institutes of Health launched the $50 Million Autism Data Science Initiative, supporting 13 pioneering projects
$3.4 Million Grant Awarded to Study Treatments for CCHFV
The National Institutes of Health granted Scott Pegan, PhD, nearly $3.4 million to lead an study to develop protective antibodies against Crimean Congo hemorrhagic fever virus
NIH Grant Awarded to Study Treatment for Crohn’s Disease
Trethera Corp., a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, has been awarded a $1.8 million National Institutes of Health (NIH) grant for preclinical studies of TRE515 as a Crohn’s disease treatment. TRE515 is a once-daily oral therapy that inhibits deoxycytidine kinase (dCK), an enzyme critical to the deoxyribonucleoside salvage […]
Study Shows No Causal Relationship Between COVID-19 Vaccination and Myositis
According to a study that analyzed the Veteran’s Health Administration records found there is no evidence to suggest COVID-19 vaccination increases the risk of developing idiopathic inflammatory myositis.
FDA Approves Expanded Label for Jascayd for PPF
Boehringer Ingelheim’s Jascayd (nerandomilast) has been given an expanded label by the U.S. Food and Drug Administration to include use in adults with progressive pulmonary fibrosis.
Lunsumio VELO Has Been Approved for R/R FL
FDA has approved CD20xCD3 bispecific Lunsumio VELO (mosunetuzumab), as a subcutaneous formulation, for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.
Study Shows mRNA Vaccine Revitalizes the Immune System
Researchers have demonstrated that weakened immune systems of older individuals can be rejuvenated using mRNA technology to transform the liver in mice into a temporary source of immune regulatory factors that are naturally lost during aging.
CDC Approves Change to Nation’s Childhood Immunization Schedule
The Centers for Disease Control and Prevention has approved a change to the nation’s childhood immunization schedule to drop the long-standing practice of giving all newborns a hepatitis B vaccine within 24 hours of birth.
FDA Approves First Gene Therapy Treatment for Wiskott-Aldrich Syndrome
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel), the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome.
Huge Study Shows mRNA COVID Vaccines Associated with 25 Percent Lower Risk Of Death From Any Cause
In a national cohort study of 28 million individuals, researchers found no increased risk of four-year all-cause mortality in individuals aged 18 to 59 years vaccinated against COVID-19, further supporting the safety of the mRNA vaccines that are widely used worldwide.